BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 26146084)

  • 1. Recurrent Fusion Genes in Gastric Cancer: CLDN18-ARHGAP26 Induces Loss of Epithelial Integrity.
    Yao F; Kausalya JP; Sia YY; Teo AS; Lee WH; Ong AG; Zhang Z; Tan JH; Li G; Bertrand D; Liu X; Poh HM; Guan P; Zhu F; Pathiraja TN; Ariyaratne PN; Rao J; Woo XY; Cai S; Mulawadi FH; Poh WT; Veeravalli L; Chan CS; Lim SS; Leong ST; Neo SC; Choi PS; Chew EG; Nagarajan N; Jacques PÉ; So JB; Ruan X; Yeoh KG; Tan P; Sung WK; Hunziker W; Ruan Y; Hillmer AM
    Cell Rep; 2015 Jul; 12(2):272-85. PubMed ID: 26146084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enrichment of CLDN18-ARHGAP fusion gene in gastric cancers in young adults.
    Nakayama I; Shinozaki E; Sakata S; Yamamoto N; Fujisaki J; Muramatsu Y; Hirota T; Takeuchi K; Takahashi S; Yamaguchi K; Noda T
    Cancer Sci; 2019 Apr; 110(4):1352-1363. PubMed ID: 30771244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of frequent CLDN18-ARHGAP26/6 fusion in gastric signet-ring cell cancer.
    Shu Y; Zhang W; Hou Q; Zhao L; Zhang S; Zhou J; Song X; Zhang Y; Jiang D; Chen X; Wang P; Xia X; Liao F; Yin D; Chen X; Zhou X; Zhang D; Yin S; Yang K; Liu J; Fu L; Zhang L; Wang Y; Zhang J; An Y; Cheng H; Zheng B; Sun H; Zhao Y; Wang Y; Xie D; Ouyang L; Wang P; Zhang W; Qiu M; Fu X; Dai L; He G; Yang H; Cheng W; Yang L; Liu B; Li W; Dong B; Zhou Z; Wei Y; Peng Y; Xu H; Hu J
    Nat Commun; 2018 Jun; 9(1):2447. PubMed ID: 29961079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of BMX-ARHGAP fusion gene inhibits epithelial-mesenchymal transition in gastric cancer cells via RhoA-mediated blockade of JAK/STAT axis.
    Xu XF; Wang JJ; Ding L; Ye JS; Huang LJ; Tao L; Gao F; Ji Y
    J Cell Biochem; 2019 Jan; 120(1):439-451. PubMed ID: 30216523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RHOA mutations and CLDN18-ARHGAP fusions in intestinal-type adenocarcinoma with anastomosing glands of the stomach.
    Hashimoto T; Ogawa R; Tang TY; Yoshida H; Taniguchi H; Katai H; Oda I; Sekine S
    Mod Pathol; 2019 Apr; 32(4):568-575. PubMed ID: 30425335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RhoGAP domain-containing fusions and PPAPDC1A fusions are recurrent and prognostic in diffuse gastric cancer.
    Yang H; Hong D; Cho SY; Park YS; Ko WR; Kim JH; Hur H; Lee J; Kim SJ; Kwon SY; Lee JH; Park DY; Song KS; Chang H; Ryu MH; Cho KS; Kang JW; Kook MC; Thiessen N; He A; Mungall A; Han SU; Kim HK
    Nat Commun; 2018 Oct; 9(1):4439. PubMed ID: 30361512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversal of the malignant phenotype of gastric cancer cells by inhibition of RhoA expression and activity.
    Liu N; Bi F; Pan Y; Sun L; Xue Y; Shi Y; Yao X; Zheng Y; Fan D
    Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6239-47. PubMed ID: 15448013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrent RhoGAP gene fusion CLDN18-ARHGAP26 promotes RHOA activation and focal adhesion kinase and YAP-TEAD signalling in diffuse gastric cancer.
    Zhang F; Sahu V; Peng K; Wang Y; Li T; Bala P; Aitymbayev D; Sahgal P; Schaefer A; Der CJ; Ryeom S; Yoon S; Sethi N; Bass AJ; Zhang H
    Gut; 2024 Apr; ():. PubMed ID: 38621923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RhoA, Claudin 18, and c-MET in Gastric Cancer: Clinicopathological Characteristics and Prognostic Significance in Curative Resected Patients.
    Pereira MA; Ramos MFKP; Dias AR; Cardili L; Ribeiro RRE; de Castria TB; Zilberstein B; Nahas SC; Ribeiro U; de Mello ES
    Med Sci (Basel); 2021 Dec; 10(1):. PubMed ID: 35076580
    [No Abstract]   [Full Text] [Related]  

  • 10. Clathrin-mediated endocytosis regulates occludin, and not focal adhesion, distribution during epithelial wound healing.
    Fletcher SJ; Poulter NS; Haining EJ; Rappoport JZ
    Biol Cell; 2012 Apr; 104(4):238-56. PubMed ID: 22187938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of the potential therapeutic target claudin-18.2 is frequently decreased in gastric cancer: results from a large Caucasian cohort study.
    Dottermusch M; Krüger S; Behrens HM; Halske C; Röcken C
    Virchows Arch; 2019 Nov; 475(5):563-571. PubMed ID: 31332522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of the expression and genetic alteration of CLDN18 in gastric cancer.
    Li J; Zhang Y; Hu D; Gong T; Xu R; Gao J
    Aging (Albany NY); 2020 Jul; 12(14):14271-14284. PubMed ID: 32668412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ARHGAP-RhoA signaling provokes homotypic adhesion-triggered cell death of metastasized diffuse-type gastric cancer.
    Komatsu M; Ichikawa H; Chiwaki F; Sakamoto H; Komatsuzaki R; Asaumi M; Tsunoyama K; Fukagawa T; Matsushita H; Boku N; Matsusaki K; Takeshita F; Yoshida T; Sasaki H
    Oncogene; 2022 Oct; 41(43):4779-4794. PubMed ID: 36127398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The RhoA pathway mediates MMP-2 and MMP-9-independent invasive behavior in a triple-negative breast cancer cell line.
    Fagan-Solis KD; Schneider SS; Pentecost BT; Bentley BA; Otis CN; Gierthy JF; Arcaro KF
    J Cell Biochem; 2013 Jun; 114(6):1385-94. PubMed ID: 23255405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HOXB7, a homeodomain protein, is overexpressed in breast cancer and confers epithelial-mesenchymal transition.
    Wu X; Chen H; Parker B; Rubin E; Zhu T; Lee JS; Argani P; Sukumar S
    Cancer Res; 2006 Oct; 66(19):9527-34. PubMed ID: 17018609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequent
    Tanaka A; Ishikawa S; Ushiku T; Yamazawa S; Katoh H; Hayashi A; Kunita A; Fukayama M
    Oncotarget; 2018 Jun; 9(50):29336-29350. PubMed ID: 30034621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clathrin dependent endocytosis of E-cadherin is regulated by the Arf6GAP isoform SMAP1.
    Kon S; Tanabe K; Watanabe T; Sabe H; Satake M
    Exp Cell Res; 2008 Apr; 314(7):1415-28. PubMed ID: 18331728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor invasion in the absence of epithelial-mesenchymal transition: podoplanin-mediated remodeling of the actin cytoskeleton.
    Wicki A; Lehembre F; Wick N; Hantusch B; Kerjaschki D; Christofori G
    Cancer Cell; 2006 Apr; 9(4):261-72. PubMed ID: 16616332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ESX induces transformation and functional epithelial to mesenchymal transition in MCF-12A mammary epithelial cells.
    Schedin PJ; Eckel-Mahan KL; McDaniel SM; Prescott JD; Brodsky KS; Tentler JJ; Gutierrez-Hartmann A
    Oncogene; 2004 Mar; 23(9):1766-79. PubMed ID: 14767472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell fusion between gastric epithelial cells and mesenchymal stem cells results in epithelial-to-mesenchymal transition and malignant transformation.
    He X; Li B; Shao Y; Zhao N; Hsu Y; Zhang Z; Zhu L
    BMC Cancer; 2015 Jan; 15():24. PubMed ID: 25633122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.